Imaflex Valuation

IFLXF Stock  USD 1.10  0.00  0.00%   
Today, the firm appears to be overvalued. Imaflex retains a regular Real Value of $1.03 per share. The prevalent price of the firm is $1.1. Our model calculates the value of Imaflex from evaluating the firm fundamentals such as Return On Asset of 0.0981, return on equity of 0.21, and Current Valuation of 53.89 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
1.10
Please note that Imaflex's price fluctuation is very risky at this time. Calculation of the real value of Imaflex is based on 3 months time horizon. Increasing Imaflex's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Imaflex pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Imaflex. Since Imaflex is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Imaflex Pink Sheet. However, Imaflex's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.1 Real  1.03 Hype  1.1
The real value of Imaflex Pink Sheet, also known as its intrinsic value, is the underlying worth of Imaflex Company, which is reflected in its stock price. It is based on Imaflex's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Imaflex's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
1.03
Real Value
2.73
Upside
Estimating the potential upside or downside of Imaflex helps investors to forecast how Imaflex pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Imaflex more accurately as focusing exclusively on Imaflex's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.061.102.80
Details

Imaflex Total Value Analysis

Imaflex is currently anticipated to have takeover price of 53.89 M with market capitalization of 58.98 M, debt of 3.5 M, and cash on hands of 5.62 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Imaflex fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
53.89 M
58.98 M
3.5 M
5.62 M

Imaflex Investor Information

About 45.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. Imaflex had not issued any dividends in recent years. Based on the key measurements obtained from Imaflex's financial statements, Imaflex is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Imaflex Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Imaflex has an asset utilization ratio of 165.37 percent. This implies that the Company is making $1.65 for each dollar of assets. An increasing asset utilization means that Imaflex is more efficient with each dollar of assets it utilizes for everyday operations.

Imaflex Ownership Allocation

Imaflex has a total of 51.74 Million outstanding shares. Imaflex secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Imaflex Profitability Analysis

The company reported the revenue of 107.48 M. Net Income was 8.37 M with profit before overhead, payroll, taxes, and interest of 17.4 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Imaflex's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Imaflex and how it compares across the competition.

About Imaflex Valuation

The pink sheet valuation mechanism determines Imaflex's current worth on a weekly basis. Our valuation model uses a comparative analysis of Imaflex. We calculate exposure to Imaflex's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Imaflex's related companies.
Imaflex Inc., together with its subsidiaries, develops, manufactures, and sells flexible packaging materials for industrial and agriculture markets in Canada, the United States, and internationally. The company was founded in 1994 and is headquartered in Montreal, Canada. Imaflex operates under Packaging Containers classification in the United States and is traded on OTC Exchange. It employs 221 people.

8 Steps to conduct Imaflex's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Imaflex's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Imaflex's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Imaflex's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Imaflex's revenue streams: Identify Imaflex's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Imaflex's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Imaflex's growth potential: Evaluate Imaflex's management, business model, and growth potential.
  • Determine Imaflex's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Imaflex's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Imaflex Growth Indicators

Investing in growth stocks can be very risky. If the company such as Imaflex does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding51.6 M
Quarterly Earnings Growth Y O Y0.2
Forward Price Earnings7.5245
Retained Earnings30.3 M

Complementary Tools for Imaflex Pink Sheet analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum